Chandrali Bhattacharya

Chandrali Bhattacharya, Ph.D., is an Associate Director at AstraZeneca since July 2020, specializing in Cardiovascular, Renal, and Metabolism (CVRM), Clinical Pharmacology, and Quantitative Pharmacology. Prior to this, Chandrali was a PhD candidate at Purdue University, where research focused on the stereoselective disposition of bupropion in animal studies. Chandrali gained experience as a Clinical Pharmacology and Pharmacometrics Intern at AbbVie, conducting pharmacokinetic analysis for cystic fibrosis treatments, and as a Summer Intern at Vertex Pharmaceuticals, developing population-pharmacokinetic models. Further experience includes research at Duquesne University on dopamine response models and drug transport studies, as well as contributions to novel drug delivery systems at Sun Pharmaceutical Advanced Research Centre. Educational credentials include a PhD in Clinical Pharmaceutical Sciences from Purdue University and a Master's degree in Pharmaceutical Technology from M.S. University, Baroda.